5HT.sub.1F agonists for the treatment of migraine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514318, 514333, 514339, A61K 31445, A61K 3144

Patent

active

057212520

ABSTRACT:
This invention provides novel 5-HT.sub.1F agonists which are useful for the treatment of migraine and associated disorders.

REFERENCES:
patent: 3850938 (1974-11-01), Derible et al.
patent: 4359468 (1982-11-01), Freter et al.
patent: 4530932 (1985-07-01), Clemence et al.
patent: 4710500 (1987-12-01), Perregaard
patent: 4742057 (1988-05-01), Ueda et al.
patent: 4997841 (1991-03-01), Oxford et al.
patent: 5001135 (1991-03-01), Oxford et al.
patent: 5017703 (1991-05-01), Matsuo et al.
patent: 5036078 (1991-07-01), Coates
patent: 5045550 (1991-09-01), Jaen
patent: 5066660 (1991-11-01), Oxford et al.
patent: 5118691 (1992-06-01), Jaen et al.
patent: 5187280 (1993-02-01), Jaen et al.
patent: 5216001 (1993-06-01), Perregaard et al.
patent: 5298520 (1994-03-01), Baker et al.
patent: 5317025 (1994-05-01), BruzMagniez
patent: 5322851 (1994-06-01), Perregaard
Tacconi et al. "Indole derivatives" CA 63:13193e (1965).
Wyngaarden et al. "Cecil Textbook of Medicine" Sauders Co., (1983) pp. 1940-1942.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

5HT.sub.1F agonists for the treatment of migraine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5HT.sub.1F agonists for the treatment of migraine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5HT.sub.1F agonists for the treatment of migraine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1875481

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.